Effect of nanotubes and apatite on growth factor release from PLLA scaffolds

Journal of Tissue Engineering and Regenerative Medicine

Volumn 5, Issue 6, 2011, Pages 476-482

  Zande, Meike van der ^a   Walboomers, X Frank ^a   Olalde, Beatriz ^b   Jurado, Maria J ^b   Álava, J Iñaki ^b   Boerman, Otto C ^a   Jansen, John A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TECNALIA RESEARCH AND INNOVATION   (Spain)

Author keywords

BMP (bone morphogenetic protein); Bone graft; Carbon nanotubes; Composite; Drug release; Hydroxyapatite; In vivo; PLLA (poly L lactic acid)

Indexed keywords

BONE; CONTROLLED DRUG DELIVERY; HYDROXYAPATITE; LACTIC ACID; PHOSPHATE MINERALS; POLYMERIC IMPLANTS; PROTEINS; SCAFFOLDS (BIOLOGY); TARGETED DRUG DELIVERY; YARN;

BONE GRAFT; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN-2; BONE MORPHOGENETIC PROTEINS; COMPOSITE SCAFFOLDS; DRUG RELEASE; GROWTH FACTOR RELEASE; IN-VIVO; POLY-L-LACTIC ACID; POLY-L-LACTIC ACIDS;

CARBON NANOTUBES;

APATITE; BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; CARBON NANOTUBE; GROWTH FACTOR; MOLECULAR SCAFFOLD; POLYLACTIC ACID; POLYMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MINERAL; CONDUCTANCE; CONTROLLED STUDY; DIFFUSION; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; RAT; STRENGTH;

EID: 79956282203     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.339     Document Type: Article

References (39)

1. Abarrategi A, Gutierrez MC, Moreno-Vicente C, et al. 2008; Multiwall carbon nanotube scaffolds for tissue engineering purposes. Biomaterials 29(1): 94-102.
2. Akman AC, Tigli RS, Gümüsderelioglu MS, et al. 2009; bFGF-loaded HA-Chitosan: a promising scaffold for periodontal tissue engineering. J Biomed Mater Res A 92A: 953-962.
3. Anderson JM, Shive MS. 1997; Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 28(1): 5-24.
4. Armentano I, Dottori M, Puglia D, et al. 2008; Effects of carbon nanotubes (CNTs) on the processing and in vitro degradation of poly(DL-lactide-co-glycolide)/CNT films. J Mater Sci Mater Med 19(6): 2377-2387.
5. Cai D, Doughty CA, Potocky TB, et al. 2007; Carbon nanotube-mediated delivery of nucleic acids does not result in non-specific activation of B lymphocytes. Nanotechnology 18: 1-10.
6. Chang PC, Liu BY, Liu CM, et al. 2007; Bone tissue engineering withnovel rhBMP2-PLLA composite scaffolds. J Biomed Mater Res A 81A(4): 771-780.
7. Chen RJ, Bangsaruntip S, Drouvalakis KA, et al. 2003; Noncovalent functionalization of carbon nanotubes for highly specific electronic biosensors. Proc Natl Acad Sci USA 100(9): 4984-4989.
8. Cui D, Tian F, Ozkan CS, et al. 2005; Effect of single wall carbon nanotubes on human HEK293 cells. Toxicol Lett 155(1): 73-85.
9. Devin JE, Attawia MA, Laurencin CT. 1996; Three-dimensional degradable porous polymer-ceramic matrices for use in bone repair. J Biomater Sci Polym Ed 7(8): 661-669.
10. Ding L, Stilwell J, Zhang T, et al. 2005; Molecular characterization of the cytotoxic mechanism of multiwall carbon nanotubes and nano-onions on human skin fibroblast. Nano Lett 5(12): 2448-2464.
11. Feng JT, Sui JH, Cai W, et al. 2008; Microstructure and mechanical properties of carboxylated carbon nanotubes/poly(L-lactic acid) composite. J Compos Mater 42(16): 1587-1595.
12. Fraker PJ, Speck JC. 1978; Protein and cell-membrane iodinations with a sparingly soluble chloramide, 1, 3, 4, 6-tetrachloro-3A, 6A-diphenylglycoluril. Biochem Biophys Res Commun 80(4): 849-857.
13. Fu YC, Nie H, Ho ML, et al. 2008; Optimized bone regeneration based on sustained release from three-dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP-2. Biotechnol Bioeng 99(4): 996-1006.
14. Harrison BS, Atala A. 2007; Carbon nanotube applications for tissue engineering. Biomaterials 28(2): 344-353.
15. Helland A, Wick P, Koehler A, et al. 2008; Reviewing the environmental and human health knowledge base of carbon nanotubes. Cien Saude Colet 13(2): 441-452.
16. Huang YX, Ren J, Chen C, et al. 2008; Preparation and properties of poly(lactide-co-glycolide) (PLGA)/nano-hydroxyapatite (NHA) scaffolds by thermally induced phase separation and rabbit MSCs culture on scaffolds. J Biomater Appl 22(5): 409-432.
17. Huczko A, Lange H. 2001; Carbon nanotubes: experimental evidence for a null risk of skin irritation and allergy. Fullerene Sci Technol 9(2): 247-250.
18. Jarcho M, Kay JF, Gumaer KI, et al. 1977; Tissue, cellular and subcellular events at a bone-ceramic hydroxy-apatite interface. J Bioeng 1(2): 79-92.
19. Keller S, Nickel J, Zhang JL, et al. 2004; Molecular recognition of BMP-2 and BMP receptor IA. Nat Struct Mol Biol 11(5): 481-488.
20. Kim K, Fisher JP. 2007; Nanoparticle technology in bone tissue engineering. J Drug Target 15(4): 241-252.
21. Kim SS, Park MS, Jeon O, et al. 2006; Poly(lactide-co-glycolide)/hydroxyapatite composite scaffolds for bone tissue engineering. Biomaterials 27(8): 1399-1409.
22. Miki T, Masaka K, Imai Y, et al. 2000; Experience with freeze-dried PGLA/HA/rhBMP-2 as a bone graft substitute. J Craniomaxillofac Surg 28(5): 294-299.
23. Moon SI, Jin F, Lee C, et al. 2005; Novel carbon nanotube/poly(L-lactic acid) nanocomposites; their modulus, thermal stability, and electrical conductivity. Macromol Sympos 224: 287-295.
24. Na K, Kim SW, Sun BK, et al. 2007; Osteogenic differentiation of rabbit mesenchymal stem cells in thermo-reversible hydrogel constructs containing hydroxyapatite and bone morphogenic protein-2 (BMP-2). Biomaterials 28(16): 2631-2637.
25. Nie H, Soh BW, Fu YC, et al. 2008; Three-dimensional fibrous PLGA/HAp composite scaffold for BMP-2 delivery. Biotechnol Bioeng 99(1): 223-234.
26. Niederwanger M, Urist MR. 1996; Demineralized bone matrix supplied by bone banks for a carrier of recombinant human bone morphogenetic protein (rhBMP-2): a substitute for autogeneic bone grafts. J Oral Implantol 22(3-4): 210-215.
27. Pistner H, Bendix DR, Muhling J, et al. 1993; Poly(L-Lactide)-A long-term degradation study in vivo. 3. Anal Charact Biomater 14(4): 291-298.
28. Ruhe PQ, Boerman OC, Russel FGM, et al. 2006; In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin. J Mater Sci Mater Med 17(10): 919-927.
29. Sayes CM, Liang F, Hudson JL, et al. 2006; Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicol Lett 161(2): 135-142.
30. Shi XF, Hudson JL, Spicer PP, et al. 2005; Rheological behaviour and mechanical characterization of injectable poly(propylene fumarate)/single-walled carbon nanotube composites for bone tissue engineering. Nanotechnology 16(7): 531-538.
31. Shim M, Kam NWS, Chen RJ, et al. 2002; Functionalization of carbon nanotubes for biocompatibility and biomolecular recognition. Nano Lett 2(4): 285-288.
32. Sitharaman B, Shi X, Walboomers XF, et al. 2008; In vivo biocompatibility of ultra-short single-walled carbon nanotube/biodegradable polymer nanocomposites for bone tissue engineering. Bone 43(2): 362-370.
33. Sitharaman B, van der Zande M, Ananta JS, et al. 2009; Magnetic resonance imaging studies on gadonanotube reinforced biodegradable polymer nanocomposites. J Biomed Mater Res A 93: 1454-1462.
34. Thies RS, Bauduy M, Ashton BA, et al. 1992; Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130(3): 1318-1324.
35. Tsai SW, Hsu FY, Chen PL. 2008; Beads of collagen-nanohydroxyapatite composites prepared by a biomimetic process and the effects of their surface texture on cellular behavior in MG63 osteoblast-like cells. Acta Biomater 4(5): 1332-1341.
36. Usui Y, Aoki K, Narita N, et al. 2008; Carbon nanotubes with high bone-tissue compatibility and bone-formation acceleration effects. Small 4(2): 240-246.
37. Warheit DB, Laurence BR, Reed KL, et al. 2004; Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci 77(1): 117-125.
38. Zhang DH, Kandadai MA, Cech J, et al. 2006; Poly(L-lactide) (PLLA)/multiwalled carbon nanotube (MWCNT) composite: characterization and biocompatibility evaluation. J Phys Chem B 110(26): 12910-12915.
39. Zhang RY, Ma PX. 1999; Poly(α-hydroxyl acids) hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology. J Biomed Mater Res 44(4): 446-455.